ArticleFrontiers in psychiatry2025
The short-term effectiveness of antidepressants in a transdiagnostic sample and determinants of side effects and medication nonadherence: an observational study.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antidepressants are widely prescribed, yet evidence on their short-term effectiveness and tolerability in routine outpatient psychiatric care remains limited. This observational study followed 123 patients newly initiated or switched to an antidepressant in a university hospital outpatient clinic to examine early-term side effects, their associations with treatment discontinuation, and predictors of short-term response in a pragmatic routine-care setting. Depression and anxiety symptoms, sociodemographic variables, and functionality were assessed at baseline; side effects and adherence were evaluated through structured interviews during the first month; and treatment response was determined at follow-up. The remission rate at one month was 72.3%, while 12.3% showed no response. Higher pretreatment anxiety levels predicted greater severity of early side effects, and lower baseline functionality predicted poorer adherence. Patients who achieved response or remission were more likely to report at least one side effect. These findings suggest that many patients struggle to maintain antidepressant treatment during the early phase, and that anxiety and functional impairment influence both tolerability and adherence. Early psychoeducation, close monitoring, and tailored support for patients with elevated anxiety or reduced functionality may improve continuity of treatment and reduce the risk of delayed recovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.